Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Post by KandiBirdBoyon Apr 28, 2021 12:20pm
94 Views
Post# 33082909

Lawrence (Larry) Latowsky

Lawrence (Larry) LatowskyLawrence (Larry) Latowsky
Mr Latowsky has over 30 years of leadership experience as a CEO and Board Director. Currently he is CEO of Canntab Therapeutics Ltd., an innovator in cannabinoid and terpene blend
in hard pill form for medical therapeutic application. He was president and CEO of Drug Trading and Katz Group Canada from 1994-2006, the largest network of
drugstores in Canada including Rexall, Pharmaplus, IDA and Guardian, a $5 Billion network of sales. Mr Latowsky is a graduate of York University and University of Toronto Rotman Business School and the Institute of Corporate Directors of Canada program and has served on many profit and non-profit Boards including Chairman of Well. ca , one of Canada’s leading e-commerce companies.
Mr. Latowsky’s experience is a unique blend of traditional retail , wholesale distribution, manufacturing and
e-commerce based marketing and sales.

<< Previous
Bullboard Posts
Next >>